Clinical trial
Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute…
NCT00008697 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00008697 |
|---|---|
| Title | Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia |
| Official title | A Phase I/II Trial of Infusional Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Enrollment | 13 |
| Start date | Nov 1, 1998 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: